Knowledge Center
Share
Follow
Systematic review of low disease activity in rheumatoid arthritis
Understanding the burden of a disease and the impact of available treatment options is critical to develop new treatment strategies. Learn how a Top 20 pharmaceutical company leveraged PharmARC’s expertise to determine the burden and economic impact of Rheumatoid Arthritis (RA) and evaluate new treatment strategies.
Download file (PDF)
The content of this page been summarised. To be able to download the full article, please register or sign in to the PharmARC web site.
